Magazine Article | August 9, 2017

Ipsen In The USA — Building & Leading The Subsidiary As Startup

By Wayne Koberstein, Executive Editor, Life Science Leader magazine
Follow Me On Twitter @WayneKoberstein

Cynthia Schwalm, president, North American commercial operations for Ipsen, heads a historic initiative by a company few people on the west side of the Atlantic have ever heard of. It all started about three years ago when the company decided to take a literal leap and go where it had only stealthily gone before — into North America, with the United States as the primary goal.

Previously, outside of the U.S., Paris-based Ipsen had both specialty care and primary care businesses. It had conducted some basic R&D at a facility in Massachusetts and acquired several small biopharma companies that enabled it to be commercially active in the U.S. since 2009.

THIS CONTENT IS EXCLUSIVELY FOR LIFE SCIENCE LEADER PAID SUBSCRIBERS.
To continue reading this story and receive uninterrupted access to LSL Online and its monthly magazine subscribe to Life Science Leader today!
Already a subscriber? Log in now.